The MUSC Health Medical Video Center
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.
Featured Videos |view more
Featured Documents |view more
Document
Precision Medicine: Exome Sequencing Helps Physicians Target Genomic Variations within Tumors
As part of MUSC's growing transnational genomics program, a genomics tumor board has been created to bring diverse specialists together to help physicians diagnose and manage cancer.
Document
Up From Below: New Minimally Invasive Surgery for Patients with Tumors in the Lower Rectum
Transanal total mesorectal excision (TaTME) has garnered a great surgery because it represents a reversal of perspective—literally— about how best to excise tumors and the surrounding mesorectal envelope in the lower third of the rectum.
Document
A Class ACT: MUSC Immunologists are Optimizng Adoptive Cell Transfer for Antitumor Treatments
Researchers are using adoptive cell transfer (ACT) to reinforce the ranks of a patient’s own T cells—the body’s warriors—and train them to better target the patient’s cancer.
Document
Taking Center Stage: Immunotherapy Joins the Ranks of Mainstream Cancer Treatments
News that novel T cell–based immunotherapeutic approaches such as immune checkpoint blockade and adoptive cell transfer are achieving durable responses in patients with aggressive cancers has created excitement in the world of cancer research.
Document
Genomics screening can improve the odds for some cancer patients, potentially identifying mutations associated with cancer subtypes for which targeted therapies exist or are in development.
Dr. Gustavo Leone will start as the new director of the Hollings Cancer Center March 1.The Medical University of South Carolina named Gustavo Leone, Ph.D., as the new director of the Hollings Cancer Center.
All content found on this Website, including: video, text, images, audio, or other formats were created for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately. MUSC does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by this website, MUSC employees, contracted writers, or medical professionals presenting content for publication to MUSC is solely at your own risk. The Site may contain health- or medical-related materials or discussions regarding graphic images, and sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis. Links to educational content not created by MUSC are taken at your own risk. MUSC is not responsible for the claims of external websites and companies.
